Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024

SELL
$268.87 - $324.56 $3.9 Million - $4.7 Million
-14,492 Reduced 47.59%
15,957 $4.54 Million
Q4 2023

Jan 17, 2024

SELL
$255.7 - $288.46 $350,564 - $395,478
-1,371 Reduced 4.31%
30,449 $8.77 Million
Q3 2023

Oct 16, 2023

BUY
$218.65 - $271.46 $6.96 Million - $8.64 Million
31,820 New
31,820 $8.55 Million
Q4 2021

Feb 08, 2022

SELL
$198.88 - $227.6 $9.08 Million - $10.4 Million
-45,653 Closed
0 $0
Q3 2021

Oct 26, 2021

SELL
$212.27 - $248.7 $1.2 Million - $1.41 Million
-5,662 Reduced 11.03%
45,653 $9.7 Million
Q2 2021

Aug 04, 2021

BUY
$233.58 - $259.14 $1.59 Million - $1.77 Million
6,825 Added 15.34%
51,315 $12.5 Million
Q1 2021

Apr 28, 2021

BUY
$221.91 - $258.6 $102,078 - $118,956
460 Added 1.04%
44,490 $11.1 Million
Q4 2020

Jan 26, 2021

BUY
$216.38 - $257.67 $1.89 Million - $2.25 Million
8,718 Added 24.69%
44,030 $10.1 Million
Q3 2020

Oct 29, 2020

SELL
$234.65 - $260.95 $9.28 Million - $10.3 Million
-39,555 Reduced 52.83%
35,312 $8.97 Million
Q2 2020

Jul 27, 2020

SELL
$197.81 - $242.74 $4.71 Million - $5.78 Million
-23,795 Reduced 24.12%
74,867 $17.7 Million
Q1 2020

Apr 14, 2020

SELL
$182.24 - $241.7 $10.1 Million - $13.4 Million
-55,325 Reduced 35.93%
98,662 $20 Million
Q4 2019

Jan 14, 2020

SELL
$189.21 - $243.2 $870,744 - $1.12 Million
-4,602 Reduced 2.9%
153,987 $37.1 Million
Q3 2019

Oct 10, 2019

SELL
$174.11 - $208.62 $2.61 Million - $3.13 Million
-15,009 Reduced 8.65%
158,589 $30.7 Million
Q2 2019

Jul 24, 2019

SELL
$166.7 - $195.41 $750,316 - $879,540
-4,501 Reduced 2.53%
173,598 $32 Million
Q1 2019

May 15, 2019

SELL
$180.87 - $203.88 $5.17 Million - $5.82 Million
-28,562 Reduced 13.82%
178,099 $33.8 Million
Q4 2018

Feb 12, 2019

BUY
$178.4 - $208.25 $15.9 Million - $18.5 Million
88,968 Added 75.59%
206,661 $40.3 Million
Q3 2018

Nov 09, 2018

BUY
$185.29 - $208.89 $13.3 Million - $15 Million
71,806 Added 156.48%
117,693 $24.4 Million
Q2 2018

Aug 08, 2018

SELL
$166.05 - $186.51 $1.48 Million - $1.67 Million
-8,933 Reduced 16.3%
45,887 $8.47 Million
Q1 2018

May 10, 2018

SELL
$169.43 - $198.0 $590,463 - $690,030
-3,485 Reduced 5.98%
54,820 $9.35 Million
Q4 2017

Feb 08, 2018

SELL
$168.79 - $188.59 $13.5 Million - $15.1 Million
-79,944 Reduced 57.83%
58,305 $10.1 Million
Q3 2017

Oct 31, 2017

SELL
$167.29 - $191.0 $272,348 - $310,948
-1,628 Reduced 1.16%
138,249 $25.8 Million
Q2 2017

Aug 09, 2017

BUY
N/A
139,877
139,877 $24.1 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $146B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Artemis Investment Management LLP Portfolio

Follow Artemis Investment Management LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artemis Investment Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Artemis Investment Management LLP with notifications on news.